Band, Hamid

Band, Vimla

Chung, Byung Min

Clubb, Robert J

George, Manju

Raja, Srikumar M

Tu, Chun

BMC Cell Biology

English

PubMed

Byung Chung

Srikumar M Raja

Robert J Clubb

Chun Tu

Manju George

Vimla Band

Hamid Band

Crossref

Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell

Association of p60c-src with endosomal membranes in mammalian fibroblasts.

Bastiaens PI: Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Traffic

Cantley LC: ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci USA

Caplan S: Mechanisms of EHD/RME-1 protein function in endocytic transport. Traffic

Cblmediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.

CL: Ligand-independent phosphorylation of Y869(Y845) links mutant EGFR signaling to stat-mediated gene expression. Exp Cell Res

Comb MJ: Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci USA

Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep

DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

DA: Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci USA

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res

DD: Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci USA

Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer

Dikic I: Suppressors of T-cell receptor signaling

Distinctive traits of normal and tumorderived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc Natl Acad Sci USA

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science

Emr SD: Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol

Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol

Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer

Fiore PP: Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell

Frame MC: Endosomal trafficking of Src tyrosine kinase. Trends Cell Biol

Fujita DJ: Selected glimpses into the activation and function of Src kinase. Oncogene

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science

GI: Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res

H: A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biol Ther

H: Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res

H: The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene

HH: Complete inhibition of transferrin recycling by monensin in K562 cells.

Hsu VW: Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic

IH: Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.

Itoh K: Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line. Mol Cancer

Kawase I: Gefitinibsensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosis.

Knobeloch KP: Essential role of ubiquitinspecific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol

Kurie JM: SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.

Lauffenburger D: HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.

MA: EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer. Oncogene

Madshus IH: Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrincoated pits. Mol Biol Cell

Madshus IH: Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Exp Cell Res

Maruyama IN: All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.

MD: c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Cell Signal

MF: Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science

MG: Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized. Cancer Res

Monensin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes.

NL: Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation. Mol Cell Biol

PA: PF0029 an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib.

Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking. Biochem Biophys Res Commun

Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. Mol Biol Cell

Review of epidermal growth factor receptor biology.

RJ: A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.

RJ: CAML is required for efficient EGF receptor recycling. Dev Cell

Shared as well as distinct roles of EHD proteins revealed by biochemical and functional comparisons in mammalian cells and C.

SL: Control of EGF receptor signaling by clathrin-mediated endocytosis. Science

SL: Regulated portals of entry into the cell. Nature

Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol

Solit DB, Arteaga CL: Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Cancer Res

Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol

Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling. Mol Cell Biol

T: c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes.

TE: Endocytic recycling. Nat Rev Mol Cell Biol

The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines. Histochem Cell Biol

TM: Oncogenes, growth factors, and signal transduction.

Yang MF: Effect of monensin on the neuronal ultrastructure and endocytic pathway of macromolecules in cultured brain neurons. Cell Mol Neurobiol

Yarden Y: c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev

Yarden Y: Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene

Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol

Yarden Y: Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene

YR: EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy. Oncogene

Z: A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation. Mol Cell Biol

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2790444

Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@

Abstract

Similar works

Full text

Available Versions

Crossref